How Indian Pharma Industry Performed in the Last Decade? Impact of a Non-macroeconomic Variable and Financial Distress

Pooja Singh and Anindita Chakraborty

Jindal Journal of Business Research, 2023, vol. 12, issue 2, 143-159

Abstract: The pharmaceutical industry in India is a significant part of the country’s international commerce, providing appealing channels and prospects for investment. The non-macroeconomic variable, like the COVID-19 pandemic, had a significant impact on the pharmaceutical industry, as well as other industries. This study examines the financial situation of pharma firms and the overall pharma industry using the Altman Z-score before and during the COVID period. Hence, the study is undertaken in three window periods. The study further describes the pharma industry’s stock return to market return and finally, the impact of overall Z-score and its ratios impact on stock return by panel data modeling. The result depicted an improved financial situation in the pharma sector due to improved investors’ confidence and higher beta in pharma stocks compared to market movement during the COVID period. Lastly, it has been analysed that Working Capital to Total Assets (WC/TA) is the significant ratio in predicting the stock return.

Keywords: Altman Z-score; financial distress; pharma sector; COVID; panel data (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/22786821231166792 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:jjlobr:v:12:y:2023:i:2:p:143-159

DOI: 10.1177/22786821231166792

Access Statistics for this article

More articles in Jindal Journal of Business Research
Bibliographic data for series maintained by SAGE Publications ().